Our story
Maresins Biopharma is a clinical stage company based in the United States, specializing in the development of molecules derived from maresins – natural compounds that support inflammation resolution. Our team of leading scientists, clinical experts and biotech specialists share a passion to turn the unique properties of maresin compounds into truly disruptive treatments targeting inflammation and pain.
Maresin compounds are naturally occurring lipids that form part of a group of Specialized Pro-resolving Mediators (SPMs), which are critical components of the inflammation resolution process. By utilizing our clinical expertise and formulation capabilities, we develop clinical trial-ready maresin compounds. Our strategy involves developing Good Manufacturing Practice (GMP)-compliant chemical analogs of maresin compounds for topical application, among other administration modes.
Despite significant advancements in the therapeutics market, current treatments for chronic pain and detrimental inflammation often fail to support disease resolution or have major side effects. We are driven by an urgent unmet need to enhance therapeutic options for people suffering from unresolved inflammation, so that they can lead healthier, happier lives.
Maresins Biopharma benefits from the expertise of highly respected experts in preclinical development, drug development, CMC (chemistry, manufacturing and controls) and quality, including
We also work in close collaboration with several scientific advisors who specialize in inflammation resolution, pain, women’s health and vulvodynia, including
Our patented compounds and formulations position us as the partner of choice for those seeking to invest in promising treatments addressing major medical needs or elevate therapeutics portfolios with unique and effective solutions. Our advanced technical capabilities and robust clinical knowledge mean we are ideally placed to create the next generation of specialized chronic inflammation treatments.